← Back to Home
Short Term·Markets Desk·Tue, 23 Jun
Mid-Horizon Plays: Analysts Identify 5 Stocks for Short-Term Gains
Research desks at Cnbc Awaaz and 2 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
By Markets Desk·10 Calls·10 Buy
Cnbc Awaaz and 2 other registered desks issued 10 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 10 buys against 0 sells — covering 5 stocks.
ZYDUSLIFE attracted 2 separate recommendations from registered analysts — Cnbc Awaaz issued a buy at ₹1,114 targeting ₹1,145 (stop ₹1,100); Cnbc Awaaz issued a buy at ₹1,114 targeting ₹1,150 (stop ₹1,100).
BAJFINANCE attracted 2 separate recommendations from registered analysts — Zee Business issued a buy at ₹965 targeting ₹1,000 (stop ₹929); Zee Business issued a buy at ₹965 targeting ₹1,035 (stop ₹929).
BIOCON attracted 4 separate recommendations from registered analysts — Zee Business issued a buy at ₹424 targeting ₹439; Zee Business issued a buy at ₹424 targeting ₹451; Zee Business issued a buy at ₹424 targeting ₹433 (stop ₹413); Zee Business issued a buy at ₹424 targeting ₹443 (stop ₹413).
Also covered: SHILPAMED (₹584.2 → ₹636.8) via Lakshmishree; KAJARIACER (₹1,180 → ₹1,220) via Zee Business.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Analyst Sources
Cnbc AwaazZee BusinessLakshmishree
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.